Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Legend Biotech Corporation stock | $52.27

Learn how to easily invest in Legend Biotech Corporation stock.

Legend Biotech Corporation is a biotechnology business based in the US. Legend Biotech Corporation shares (LEGN) are listed on the NASDAQ and all prices are listed in US Dollars. Legend Biotech Corporation employs 900 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Legend Biotech Corporation

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – LEGN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Legend Biotech Corporation stock price (NASDAQ: LEGN)

Use our graph to track the performance of LEGN stocks over time.

Legend Biotech Corporation shares at a glance

Information last updated 2021-10-25.
Latest market close$52.27
52-week range$23.41 - $58.00
50-day moving average $47.86
200-day moving average $39.84
Wall St. target price$58.40
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.21

Buy Legend Biotech Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Legend Biotech Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Legend Biotech Corporation price performance over time

Historical closes compared with the close of $52.27 from 2021-10-26

1 week (2021-10-20) -3.99%
1 month (2021-09-27) 11.24%
3 months (2021-07-27) 25.50%
6 months (2021-04-27) 74.12%
1 year (2020-10-27) 87.41%
2 years (2019-10-23) N/A
3 years (2018-10-23) N/A
5 years (2016-10-23) N/A

Legend Biotech Corporation financials

Revenue TTM $88.9 million
Gross profit TTM $78.7 million
Return on assets TTM -22.17%
Return on equity TTM -80.13%
Profit margin 0%
Book value $2.56
Market capitalisation $7.7 billion

TTM: trailing 12 months

Shorting Legend Biotech Corporation shares

There are currently 1.5 million Legend Biotech Corporation shares held short by investors – that's known as Legend Biotech Corporation's "short interest". This figure is 16.4% up from 1.3 million last month.

There are a few different ways that this level of interest in shorting Legend Biotech Corporation shares can be evaluated.

Legend Biotech Corporation's "short interest ratio" (SIR)

Legend Biotech Corporation's "short interest ratio" (SIR) is the quantity of Legend Biotech Corporation shares currently shorted divided by the average quantity of Legend Biotech Corporation shares traded daily (recently around 383552.14105793). Legend Biotech Corporation's SIR currently stands at 3.97. In other words for every 100,000 Legend Biotech Corporation shares traded daily on the market, roughly 3970 shares are currently held short.

However Legend Biotech Corporation's short interest can also be evaluated against the total number of Legend Biotech Corporation shares, or, against the total number of tradable Legend Biotech Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Legend Biotech Corporation's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Legend Biotech Corporation shares in existence, roughly 10 shares are currently held short) or 0.0464% of the tradable shares (for every 100,000 tradable Legend Biotech Corporation shares, roughly 46 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Legend Biotech Corporation.

Find out more about how you can short Legend Biotech Corporation stock.

Legend Biotech Corporation share dividends

We're not expecting Legend Biotech Corporation to pay a dividend over the next 12 months.

Legend Biotech Corporation overview

Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in North America and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM), as well as a comparison of the treatment with standard triplet therapy in relapsed and refractory multiple myeloma. The company also has a portfolio of earlier-stage autologous product candidates targeting various cancers, including non-hodgkins lymphoma (NHL), acute myeloid leukemia, and T cell lymphoma. In addition, it is developing allogeneic CAR-T product candidates targeting CD20 for the treatment of NHL and targeting B-cell maturation antigen for the treatment of MM, which are currently in an investigator-initiated Phase 1 clinical trial in China. Further, the company has product candidates in early preclinical and clinical development for the treatment of solid tumors as well as infectious diseases. Legend Biotech Corporation was founded in 2014 and is based in Somerset, New Jersey. Legend Biotech Corporation is a subsidiary of Genscript Biotech Corporation.

Frequently asked questions

What percentage of Legend Biotech Corporation is owned by insiders or institutions?
Currently 0.502% of Legend Biotech Corporation shares are held by insiders and 22.533% by institutions.
How many people work for Legend Biotech Corporation?
Latest data suggests 900 work at Legend Biotech Corporation.
When does the fiscal year end for Legend Biotech Corporation?
Legend Biotech Corporation's fiscal year ends in December.
Where is Legend Biotech Corporation based?
Legend Biotech Corporation's address is: 2101 Cottontail Lane, Somerset, NJ, United States, 08873
What is Legend Biotech Corporation's ISIN number?
Legend Biotech Corporation's international securities identification number is: US52490G1022

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site